KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Current Assets (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Current Assets for 16 consecutive years, with $126.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Assets rose 41.6% to $126.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $126.6 million, a 41.6% increase, with the full-year FY2024 number at $148.8 million, up 23.35% from a year prior.
  • Current Assets was $126.6 million for Q3 2025 at Biolife Solutions, up from $125.4 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $148.8 million in Q4 2024 to a low of $88.2 million in Q2 2024.
  • A 5-year average of $122.3 million and a median of $125.4 million in 2025 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: soared 340.62% in 2021, then decreased 26.69% in 2024.
  • Biolife Solutions' Current Assets stood at $126.1 million in 2021, then rose by 9.81% to $138.5 million in 2022, then fell by 12.89% to $120.6 million in 2023, then rose by 23.35% to $148.8 million in 2024, then dropped by 14.92% to $126.6 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Current Assets are $126.6 million (Q3 2025), $125.4 million (Q2 2025), and $131.1 million (Q1 2025).